INDIVIOR PLC (INVVY)

7.25
OTC Markets
Prev Close 7.00
Day Low/High 7.06 / 7.49
52 Wk Low/High 4.73 / 33.83
Exchange OTC Markets
Shares Outstanding 728.77B
Market Cap 1.02B
Div & Yield N.A. (N.A)

Latest News

Indivior Publishes Design And Patient Characteristics For Real-World Study Of Life Changes In People Treated With SUBLOCADE™ (Buprenorphine Extended-Release) In Contemporary Clinical Trials

Indivior Publishes Design And Patient Characteristics For Real-World Study Of Life Changes In People Treated With SUBLOCADE™ (Buprenorphine Extended-Release) In Contemporary Clinical Trials

RECOVER study designed to understand the long-term clinical, environmental and socio-economic outcomes of SUBLOCADE treated individuals

Aquestive Therapeutics Provides End Of Year Business Update, Including Progress Of Its Proprietary CNS Assets, Financial And Legal Matters

Aquestive Therapeutics Provides End Of Year Business Update, Including Progress Of Its Proprietary CNS Assets, Financial And Legal Matters

- Projects full year 2018 revenues over $67 million, exceeding expectations, and projects end-of-year cash and cash equivalents in the range of $58 million to $60 million

Commercial Launch Plans Announced For PERSERIS™ (risperidone) Extended-Release Injectable Suspension For The Treatment Of Schizophrenia In Adults

Commercial Launch Plans Announced For PERSERIS™ (risperidone) Extended-Release Injectable Suspension For The Treatment Of Schizophrenia In Adults

Indivior PLC Announces Plan for Commercial Launch in February 2019 with 50 Sales Representatives

Court Of Appeals For The Federal Circuit Declines To Immediately Issue Mandate After Preliminary Injunction Ruling

Court Of Appeals For The Federal Circuit Declines To Immediately Issue Mandate After Preliminary Injunction Ruling

SLOUGH, England, Dec. 12, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.

Indivior To Host Conference Call On December 18th; Previously-Scheduled Capital Markets Day To Be Held In February 2019

Indivior To Host Conference Call On December 18th; Previously-Scheduled Capital Markets Day To Be Held In February 2019

SLOUGH, England, Nov. 27, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that in light of the recent decision by the Court of Appeals for the Federal Circuit (CAFC) vacating the preliminary injunction against...

Indivior Announces Health Canada Approval Of SUBLOCADETM (Buprenorphine Extended-Release) Injection For Patients With Moderate To Severe Opioid Use Disorder

Indivior Announces Health Canada Approval Of SUBLOCADETM (Buprenorphine Extended-Release) Injection For Patients With Moderate To Severe Opioid Use Disorder

SUBLOCADE is the first and only once-monthly injectable buprenorphine formulation approved in Canada for the management of moderate to severe opioid use disorder SLOUGH, England and RICHMOND, Va.

Court Of Appeals For The Federal Circuit Lifts Preliminary Injunction On Generic (buprenorphine And Naloxone) Sublingual Film

Court Of Appeals For The Federal Circuit Lifts Preliminary Injunction On Generic (buprenorphine And Naloxone) Sublingual Film

-Company will continue to defend its intellectual property and implement contingency plan­

PERSERIS™, The First Once-Monthly Risperidone-Containing Subcutaneous Long-Acting Injectable, Now Available In The U.S. For The Treatment Of Schizophrenia In Adults

PERSERIS™, The First Once-Monthly Risperidone-Containing Subcutaneous Long-Acting Injectable, Now Available In The U.S. For The Treatment Of Schizophrenia In Adults

PERSERIS delivers risperidone in a new once-monthly extended-release delivery system. Neither a loading dose nor any supplemental oral risperidone is recommended.

Indivior Announces Upcoming Investor Events

Indivior Announces Upcoming Investor Events

SLOUGH, United Kingdom and RICHMOND, Va., Nov.

Indivior Announces Nine Month And Third Quarter 2018 Results

Indivior Announces Nine Month And Third Quarter 2018 Results

SLOUGH, United Kingdom and RICHMOND, Va., Nov.

Indivior Applauds Enactment Of The SUPPORT For Patients And Communities Act Of 2018

Indivior Applauds Enactment Of The SUPPORT For Patients And Communities Act Of 2018

Act Broadens Access to Medication-Assisted Treatment for People Affected by Opioid Addiction

Indivior Provides Update On Key Business Drivers And Expectations

Indivior Provides Update On Key Business Drivers And Expectations

This announcement contains inside information.

Indivior Unable To Participate In Morgan Stanley Healthcare Conference Due To Adverse Weather

Indivior Unable To Participate In Morgan Stanley Healthcare Conference Due To Adverse Weather

SLOUGH, England and RICHMOND, Va., Sept.

Indivior Prepays $150 Million Of Outstanding Debt

Indivior Prepays $150 Million Of Outstanding Debt

SLOUGH, England and RICHMOND, Va., Sept.

DURECT Announces Receipt Of $5 Million Milestone Payment From Indivior

DURECT Announces Receipt Of $5 Million Milestone Payment From Indivior

Milestone payment triggered by NDA approval of PERSERIS™ (risperidone)

The 6 Medications Being Used to Tackle the Opioid Epidemic

The 6 Medications Being Used to Tackle the Opioid Epidemic

The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.

Indivior Shares Plunge Amid Generics Threat to Suboxone Opioid Treatment

Indivior Shares Plunge Amid Generics Threat to Suboxone Opioid Treatment

The FTSE 250 pharmaceutical company said the U.S. District Court in Delaware has found that claims of a proposed generic version of Indivior's opioid addiction treatment by Dr. Reddy's does not infringe patents.

European Stock Markets Fall on Growth Worries, Oil Price Declines

European Stock Markets Fall on Growth Worries, Oil Price Declines

Société Générale, Deutsche Bank among biggest losers.

States Accuse Heroin Addiction Treatment Maker Indivior of Blocking Generics

States Accuse Heroin Addiction Treatment Maker Indivior of Blocking Generics

Indivior shares drop 16% in London on news of the lawsuit.

European Markets Down Ahead of Fed Minutes

European Markets Down Ahead of Fed Minutes

Semiconductor industry player ASML falls on reported snub from Intel.

European Markets Open Mostly Down; ASML Falls on Intel Snub

European Markets Open Mostly Down; ASML Falls on Intel Snub

U.S. futures point to markets opening in the red.